Johnson & Johnson proposes $6.5bn deal to settle talc cancer lawsuits
Published
Drugmaker could fast track subsidiary’s bankruptcy process if 75% of claimants vote in favour of new plan
Full ArticlePublished
Drugmaker could fast track subsidiary’s bankruptcy process if 75% of claimants vote in favour of new plan
Full ArticleJohnson & Johnson (JNJ.N) announced on Wednesday a significant move towards resolving ongoing litigation over its baby powder and..
A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement in the..